指南与共识免疫规划卫生政策与健康促进

对免疫实践咨询委员会肺炎球菌疫苗接种建议的依从性

Compliance to Advisory Committee on Immunization Practices recommendations for pneumococcal vaccination.
指南 / 共识 · Vaccine · 2022-03-12

研究利用MarketScan商业与Medicare补充数据库(2007年1月至2019年6月)评估成人对ACIP肺炎球菌疫苗建议的依从性。≥65岁成人4年部分依从率为53%、完全依从率为17%;高风险1组6年部分依从率19%、完全依从率5%;高风险2组6年完全依从率20%。作者认为需进一步努力以提高依从性。

要点

  • ≥65岁成人4年时部分依从率为53%,完全依从率为17%。
  • 高风险1组6年时部分依从率为19%,完全依从率为5%。
  • 高风险2组6年时完全依从率为20%,糖尿病患者最高为27%,酒精中毒患者最低为8%。

核心结论

  • 需要额外努力以最大化≥65岁成人及高风险状况成人对ACIP肺炎球菌疫苗建议的依从性,包括简化建议和单剂疫苗,这些努力可能随后降低肺炎球菌病的发生率和负担。

研究设计与样本

  • 利用MarketScan®商业与Medicare补充数据库(2007年1月至2019年6月)识别兴趣队列,对≥65岁成人的分析进行了调整以考虑疫苗接种史缺失,并识别了两个高风险队列:高风险1组包括免疫受损状况、功能或解剖性无脾、脑脊液漏或人工耳蜗患者;高风险2组包括慢性心脏、肺或肝脏疾病、糖尿病、酒精中毒、肝硬化或吸烟患者。
  • 年度依从率采用Kaplan-Meier法估计。

主要发现

  • 在≥65岁成人中,调整分析显示索引后4年部分依从率为53%,完全依从率为17%。
  • 在≥65岁接受第一剂疫苗接种的受试者中,42%在4年时接受了第二剂疫苗。
  • 高风险1组索引日期后6年部分依从率为19%,完全依从率为5%。
  • 高风险2组6年完全依从率为20%,其中糖尿病患者依从率最高为27%,酒精中毒患者最低为8%。

关键数值与推荐

  • ≥65岁成人或高风险1组的完全依从定义为接种PCV13和PPSV23,部分依从定义为接种PCV13或PPSV23。
  • 高风险2组的完全依从定义为接种PPSV23。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We evaluated compliance to the ACIP pneumococcal vaccination recommendations issued in 2014 for adults aged ≥ 65 years and in 2012 for adults with high-risk (HR) conditions. The MarketScan® Commercial and Medicare Supplemental databases (January 2007-June 2019) were used to identify the cohorts of interest. Analyses for adults aged ≥ 65 years were adjusted to account for missing vaccination history. Two HR cohorts were identified. The HR1 cohort included patients with immunocompromising conditions, functional or anatomic asplenia, cerebrospinal fluid leak, or cochlear implant. The HR2 cohort included patients with chronic heart, lung, or liver disease; diabetes mellitus; alcoholism; cirrhosis; or cigarette smoking. Full compliance for those aged ≥ 65 years or in the HR1 cohort was defined as receipt of PCV13 and PPSV23, and partial compliance was defined as receipt of PCV13 or PPSV23. For those in the HR2 cohort, full compliance was defined as receipt of PPSV23. Annual compliance rates were estimated using the Kaplan-Meier method. Among those aged ≥ 65 years, partial compliance at 4 years post index was 53% and full compliance was 17% in adjusted analyses. In subjects ≥ 65 years receiving the first vaccination, 42% received the second vaccination by year 4. For the HR1 cohort, partial compliance was 19% and full compliance was 5% at 6 years post index date. For the HR2 cohort, full compliance was 20% at 6 years, with the highest rate in patients with diabetes (27%) and the lowest rate in patients with alcoholism (8%). Additional efforts are needed to maximize compliance to the ACIP pneumococcal vaccine recommendations among adults ≥ 65 years of age and adults with HR conditions including streamlined recommendations and single-dose vaccines. These efforts may subsequently reduce the incidence and burden of pneumococcal disease.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Morga A, Kimura T, Feng Q, et al. Compliance to Advisory Committee on Immunization Practices recommendations for pneumococcal vaccination. Vaccine. 2022. PMID: 35292161. doi:10.1016/j.vaccine.2022.03.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。